Advertisement

The Latest

Today begins Operation Walk USA 2011, an initiative that will provide 85 patients in the United States with joint replacement procedures they couldn't otherwise afford, according to an American Academy of Orthopaedic Surgeons news release.

Michel Orsinger, CEO of Synthes, recently received $52 million as a result of Johnson & Johnson's acquisition of the company, if the deal closes sometime over the next two years, according to a Philadelphia Inquirer report.

Pain management is a specialty in flux. Not only are more chronic pain sufferers seeking out treatment, but the release of a recent Center for Disease Control report, which found more people die from prescription drug overdoses than heroin and…

Advertisement